30 May The Center for Forensic Science Research & Education (CFSRE) Publishes An Alert Regarding 2F-2oxo-PCE
On May 30, 2024, The Center for Forensic Science Research & Education (CFSRE) published an alert regarding 2F-2oxo-PCE, a substance that has similar characteristics to ketamine. This is a drug that is not currently regulated in the United States, produces dissociative effects when used, and has been found in several states across the country.
The drug was first identified in Australia, but has since been detected in both drug materials and toxicology samples. Use of this drug has been associated with both intoxication and fatalities, and it has been found alongside other potent, high-risk substances. The CSFRE report states that “…drug materials containing 2F-2oxo-PCE also contained opioids, primarily fentanyl. Xylazine, NPS benzodiazepines, and nitazene analogues were common co-occurrences alongside 2F-2oxo-PCE.”
Read the full alert here.
Aegis implemented testing for this drug in September 2023, and in cases where use is suspected, it can be tested in both urine and oral fluid specimens. More information on our NPS testing can be found here.
